#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adenocarcinoma gastric Noonan syndrome Barth syndrome Kaposi's sarcoma Cutaneous T-cell lymphoma refractory Biotinidase deficiency Neonatal alloimmune thrombocytopenia Ovarian cancer stage III Scleroderma associated digital ulcer Transferrin decreased Cervix carcinoma recurrent Glomerulonephritis acute Myxofibrosarcoma Acquired ATTR amyloidosis Chondrosarcoma metastatic More trials…

    Learn about Rare Diseases

    Focal segmental glomerulosclerosis – Trials in Disease Mastocytosis – Basic Information Testicular leiomyosarcoma – Life with Disease Hereditary neuropathic amyloidosis – Trials in Disease Cystic fibrosis lung – Treatment Ewing’s sarcoma – Trials in Disease Malignant fibrous histiocytoma Mucopolysaccharidosis – Life with Disease Marfan’s syndrome – Trials in Disease Marginal zone lymphoma refractory – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Salbutamol SODIUM TETRACHLOROPALLADATE CAMOSTAT MESILATE Calcium Chloride Dihydrate ZIRCONIUM (89ZR) GIRENTUXIMAB Domperidone Riluzole Sym025 Secale Cereale Apremilast Corline Heparin Conjugate Paeonol Potassium Obexelimab Dexibuprofen Bisoprolol Fumarate Troriluzole Gadobenate Dimeglumine ALN-4324 Immunoglobulin A More therapies…

    Learn about Your Condition

    Thrombocytosis Malignant melanoma stage II Tardive dyskinesia Oesophageal food impaction Vascular graft thrombosis Mite allergy Vulval cancer Pulmonary hypertension Viral infection Schizophrenia Neuroblastoma recurrent Cutaneous T-cell lymphoma Sinusitis bacterial Follicular lymphoma stage IV Rett syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Siplizumab, Cyclophosphamide, and Splenectomy for Preventing Liver Transplant Rejection in Patients Receiving a Deceased Donor Liver

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Siplizumab
    Sweden

  • Study on the Safety of Autologous Adipose Tissue-Derived Stromal Vascular Fraction Cells for Patients with Recurrent Urethral Stricture

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Urethral stenosis
    Investigated Drugs:
    • Autologous Adipose Tissue-Derived Stromal Vascular Fraction Cells
    France

  • Study of DYP688 for Patients with Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Skin cancer
    • Uveal melanoma
    Investigated Drugs:
    • Dyp688
    France Germany The Netherlands Spain

  • Study on Immune Response in COVID-19 Recovered Patients Treated with Monoclonal Antibodies: Effects of Revaccination with Elasomeran, Tozinameran, and Cilgavimab

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Cilgavimab
    • Elasomeran
    • Sars-Cov-2, Spike Protein, Recombinant, Expressed In Sf9 Cells Derived From Spodoptera Frugiperda
    Italy

  • Study of Selinexor and Gemcitabine for Patients with Advanced Soft-Tissue Sarcoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Soft tissue sarcoma
    Investigated Drugs:
    • Selinexor
    • Gemcitabine
    Spain

  • Study on Oxaliplatin and Capecitabine for Patients with Locally Advanced Rectal Cancer

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Rectal adenocarcinoma
    • Rectal cancer stage III
    Investigated Drugs:
    • Oxaliplatin
    Italy
Previous Page
1 … 834 835 836 837 838 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!